Lv11
50 积分 2024-03-17 加入
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer
1小时前
求助中
Sintilimab plus anlotinib as second‐ or third‐line therapy in metastatic non‐small cell lung cancer with uncommon epidermal growth factor receptor mutations: A prospective, single‐arm, phase II trial
1个月前
已完结
Comparison Of Anlotinib Combined With Docetaxel Versus Single Docetaxel As Second-Line Treatment Beside Radiotherapy For Advanced Non-Small Cell Lung Cancer: Efficacy And Safety
1个月前
已完结
A randomized double-blind trial of TQB2450 with or without anlotinib in pretreated driver-negative non-small cell lung cancer
1个月前
已完结
Anlotinib Plus Docetaxel is Promising in Advanced NSCLC Progressing on First-Line Immunotherapy: A Pooled Analysis of Two Randomized Trials
1个月前
已完结
Afatinib plus bevacizumab combination after osimertinib resistance in advanced EGFR-mutant non-small cell lung cancer: Phase II ABCD-study
1个月前
已完结
Osimertinib combined with anlotinib as first-line treatment in advanced or metastatic NSCLC patients with EGFR mutation: a prospective, single arm, exploratory study
1个月前
已关闭
β‐Sitosterol attenuates anlotinib resistance in non‐small cell lung cancer cells by inhibiting miR‐181a‐3p/SHQ1 signaling
1个月前
已完结
Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway
2个月前
已完结
基于玄府理论麻黄附子甘草汤及其辛味单药成分干预原发性足细胞病TRPC5-RAC1前馈循环的机制
2个月前
已完结
皖公网安备34019202002308
